Stocktoria
Tyra Biosciences, Inc. TYRA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-09-15
Chart by TradingView
1/9
Piotroski F — financial health
9.92
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$132.8M | -$104.2M | -$79.9M | -$58.9M | -$26.3M |
| Net income | -$119.9M | -$86.5M | -$69.1M | -$55.3M | -$26.3M |
| Operating cash flow | -$95.1M | -$69.8M | -$50.1M | -$50.3M | -$23.7M |
| Free cash flow | -$95.3M | -$70.4M | -$50.9M | -$50.8M | -$24.4M |
| Total assets | $282.6M | $363.6M | $225.9M | $266.2M | $306.7M |
| Total liabilities | $23.4M | $20.4M | $21.6M | $8.4M | $5.0M |
| Shareholders' equity | $259.2M | $343.2M | $204.3M | $257.8M | $301.7M |
| Ratios | |||||
| Return on assets | -42.4% | -23.8% | -30.6% | -20.8% | -8.6% |
| Return on equity | -46.3% | -25.2% | -33.8% | -21.5% | -8.7% |
| Current ratio | 14.67 | 23.81 | 13.80 | 45.13 | 84.09 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 218,950 | $8.4M |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 9.92 (safe)
- Working capital / assets 0.875
- Retained earnings / assets -1.314
- EBIT / assets -0.47
- Equity / liabilities 11.061
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001863127 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.